Transposon to Present Results from Phase 2 Study of TPN-101 for the Treatment of C9orf72-Related ALS/FTD at the 7th Annual ALS ONE Research Symposium
Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative and aging-related diseases, including Alzheimer's ...
Queen wraps up Labuan visit, advocates for local welfare, education, tourism growth
LABUAN: Her Majesty Raja Zarith Sofiah, Queen of Malaysia, has concluded her inaugural two-day working visit to Labuan, ...